Literature DB >> 19837417

Differential diagnosis of overactive bladder in men.

Jerry G Blaivas1, Brian K Marks, Jeffrey P Weiss, Georgia Panagopoulos, Chandra Somaroo.   

Abstract

PURPOSE: We determined the differential diagnosis of concomitant pathological conditions in men with overactive bladder symptoms.
MATERIALS AND METHODS: We performed an observational, descriptive study to elucidate the differential diagnosis in men with overactive bladder symptoms using a previously validated overactive bladder symptom questionnaire. All patients provided an extensive history, completed the self-administered questionnaire and a 24-hour voiding diary, and underwent physical examination, 24-hour pad test, uroflowmetry, post-void residual urine measurement, cystoscopy and urodynamics. Selection criteria were developed to assign cases to a category, including idiopathic overactive bladder, benign prostatic enlargement, benign prostatic obstruction, neurogenic bladder, bladder cancer, prostate cancer treatment complications, urethral stricture, bladder stones and bladder diverticulum.
RESULTS: Of 122 men who met selection criteria for overactive bladder detrusor overactivity was identified in 99 (79%) on urodynamics. The differential diagnosis was benign prostatic enlargement in 40 men (32%), benign prostatic obstruction in 27 (22%), complications of prostate cancer treatment in 25 (20%), neurogenic bladder in 13 (11%), urethral stricture in 7 (6%), idiopathic overactive bladder in 6 (5%), bladder stone in 2 (2%), bladder cancer in 1 (1%) and bladder diverticulum in 1 (1%).
CONCLUSIONS: Overactive bladder is a complex diagnosis with many underlying, contributing urological pathologies. It should be considered a symptom complex and not a syndrome. Knowledge of the differential diagnosis in men with overactive bladder symptoms would hopefully provide clinicians with a diagnostic rubric to more specifically treat such patients with improved success.

Entities:  

Mesh:

Year:  2009        PMID: 19837417     DOI: 10.1016/j.juro.2009.08.039

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Overactive bladder: a new paradigm.

Authors:  Jerry G Blaivas
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-10-29

2.  Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Long-Wang Wang; Jian-Long Li; Yi Yu; Rui-Hai Xiao; Hong-Wei Huang; Ren-Rui Kuang; Bo Hai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

3.  Urogynecological conditions associated with overactive bladder symptoms in women.

Authors:  James C Forde; Jonathan L Davila; Brian K Marks; Matthew Epstein; Johnson F Tsui; Jeffrey P Weiss; Jerry G Blaivas
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

4.  The performance of silk scaffolds in a rat model of augmentation cystoplasty.

Authors:  Abhishek Seth; Yeun Goo Chung; Eun Seok Gil; Duong Tu; Debra Franck; Dolores Di Vizio; Rosalyn M Adam; David L Kaplan; Carlos R Estrada; Joshua R Mauney
Journal:  Biomaterials       Date:  2013-03-29       Impact factor: 12.479

5.  Long-term alpha-blockers and anticholinergic combination treatment for men with lower urinary tract symptoms in real-life practice.

Authors:  Woong Jin Bae; Jang Ho Bae; Yong Sun Choi; Su Jin Kim; Hyuk Jin Cho; Sung Hoo Hong; Sae Woong Kim; Tae-Kon Hwang; Ji Youl Lee
Journal:  Int Urol Nephrol       Date:  2012-04-15       Impact factor: 2.370

6.  'Tamsulosin and Darifenacin' Versus 'Tamsulosin Monotherapy' for 'BPH with Accompanying Overactive Bladder'.

Authors:  Iqbal Singh; Vivek Agarwal; Gaurav Garg
Journal:  J Clin Diagn Res       Date:  2015-06-01

7.  Effects of Panax ginseng on the nerve growth factor expression in testosterone induced benign prostatic hyperplasia.

Authors:  Su Kang Kim; Il GyuKo; Hae Jeong Park; Joo-Ho Chung; Kyu Bong Cho; Oh Young Kwon; Kyeong Hun Park; Young Sub Ahn; Chun Geon Park; Young Ock Kim
Journal:  Saudi J Biol Sci       Date:  2016-08-13       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.